Dashboard
ATOS
NASDAQAtossa Therapeutics · Biotechnology
$1.27
76WatchlistMarket Cap
$155M
Float
121M
Avg Volume
1.3M
RVOL
3.2×
ADR
$0.14
ATR
$0.19
What if I bought 100 shares?
demo simulatorCurrent Price
$1.27
Cost
$127.00
Expected Move
±$1.02
Profit Potential
+$102.00
Loss Risk
-$61.20
Risk / Reward1.67 : 1
Trade Setup Generator
Confidence 61 Entry Zone
$1.25 – $1.28
Stop Loss
$1.12
R / R
4.53 : 1
Target 1
$1.49
Target 2
$1.95
Target 3
$2.56
AI explanation
ATOS ranks in the top tier of AlphaRadar's Dollar Move scanner (76/100) thanks to a bullish MACD, 3.2× relative volume, and a near-term catalyst: conference abstract. Breakout retest of $1.20 prior resistance.
- Bullish: Conference abstract release historically moves shares >50%.
- Risks: Single-trial concentration.
- Setup: Breakout retest of $1.20 prior resistance.
- Catalyst: Conference abstract in 11 days.
Position Size Calculator
Shares
1,666
Capital Required
$2115.82
Max Loss
-$250.00
Profit @ T1
+$366.52
Profit @ T2
+$1132.88
Profit @ T3
+$2149.14
Company Overview
Clinical-stage biotech focused on breast cancer therapeutics.
Why This Stock Could Move
Bull Case
Conference abstract release historically moves shares >50%.
Bear Case
Low coverage; thin liquidity intra-day.
Technical Setup
Breakout retest of $1.20 prior resistance.
Key Risks
Single-trial concentration.
Potential Catalyst
Conference abstract in 11 days.
Movement Projection
Expected move (next 5d)±$1.02
Avg move after catalyst$1.00
Historical volatility89%
ATR$0.19
News
No recent news.
Score Breakdown
Technical88
Fundamental50
Sentiment73
Catalyst Proximity78
Risk Score7/10
Support & Resistance
Support$1.14
Resistance$1.52
Breakout target$1.95
Stop loss$1.12
Risk / reward4.53 : 1
Technical Snapshot
RSI64
MACDBullish
MA CrossoverGolden
Volume4.1M (3.2×)